| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A rapid test for measuring the infectivity of Yellow Fever vaccine
|
Sood, D.K.
|
|
1995
|
13 |
5 |
p. 427-428
2 p.
|
article
|
| 2 |
Calendar
|
|
|
1995
|
13 |
5 |
p. 518-
1 p.
|
article
|
| 3 |
Effect of DETOX as an adjuvant for melanoma vaccine
|
Schultz, Neil
|
|
1995
|
13 |
5 |
p. 503-508
6 p.
|
article
|
| 4 |
Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2
|
Kotloff, Karen L.
|
|
1995
|
13 |
5 |
p. 495-502
8 p.
|
article
|
| 5 |
Hamster cell lines stably expressing Epstein-Barr virus antigens; glycoprotein gene expression in a CHO-K6 cell culture, and gene amplification using a dihydrofolate-reductase selectable marker, for use as a recombinant vaccine
|
|
|
1995
|
13 |
5 |
p. 517-
1 p.
|
article
|
| 6 |
Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles
|
Cahill, E.S.
|
|
1995
|
13 |
5 |
p. 455-462
8 p.
|
article
|
| 7 |
Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazide
|
Bartoloni, Antonella
|
|
1995
|
13 |
5 |
p. 463-470
8 p.
|
article
|
| 8 |
Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus
|
Hsu, Kuo-Hom L.
|
|
1995
|
13 |
5 |
p. 509-515
7 p.
|
article
|
| 9 |
35 31 kDa subunit of the Entamoeba histolytica adherence lectin; application as a recombinant vaccine, and use of an antisense oligonucleotide for diagnosis
|
|
|
1995
|
13 |
5 |
p. 517-
1 p.
|
article
|
| 10 |
Prevention or treatment of autoimmune diseases, especially diabetes; insulin, glutamate-decarboxylase GAD65 or glucagon gene cloning in Mycobacterium bovis BCG or a vaccinia virus vector for use as a recombinant vaccine for e.g. diabetes
|
|
|
1995
|
13 |
5 |
p. 517-
1 p.
|
article
|
| 11 |
Protection against ricin intoxication in vivo by anti-idiotype vaccination
|
Chanh, Tran C.
|
|
1995
|
13 |
5 |
p. 479-485
7 p.
|
article
|
| 12 |
Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence
|
Gesemann, Michael
|
|
1995
|
13 |
5 |
p. 443-447
5 p.
|
article
|
| 13 |
Recombinant BCG strains expressing the SIVmac251 nef gene induce proliferative and CTL responses against nef synthetic peptides in mice
|
Winter, Nathalie
|
|
1995
|
13 |
5 |
p. 471-478
8 p.
|
article
|
| 14 |
Search for optimal parent for recombinant vaccinia virus vaccines. Study of three vaccinia virus vaccinal strains and several virus lines derived from them
|
Kutinová, L.
|
|
1995
|
13 |
5 |
p. 487-493
7 p.
|
article
|
| 15 |
Synthesis and characterization of a polyvalent Escherichia coli O-polysaccharide-toxin A conjugate vaccine
|
Cryz Jr, S.J.
|
|
1995
|
13 |
5 |
p. 449-453
5 p.
|
article
|
| 16 |
The influence of gamma inulin and Algammulin on the immune response in sheep to a recombinant antigen of Taenia ovis
|
Deol, Harjit S.
|
|
1995
|
13 |
5 |
p. 429-433
5 p.
|
article
|
| 17 |
The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi
|
Golde, William T.
|
|
1995
|
13 |
5 |
p. 435-441
7 p.
|
article
|
| 18 |
Treating or preventing Kawasaki syndrome; recombinant vaccine containing a Staphylococcus aureus toxic shock syndrome toxin-1 superantigen mutant
|
|
|
1995
|
13 |
5 |
p. 517-
1 p.
|
article
|
Journal description